Desktop version

Home arrow Economics arrow American Trypanosomiasis Chagas Disease, Second Edition: One Hundred Years of Research

References

  • 1. Wendel S. Transfusion transmitted Chagas disease: is it really under control? Acta Trop 2010;115:28-34.
  • 2. Pedreira De Freitas JL, Amato Neto V, Nussenzweig V, Sonntag R, Barreto JG. Primeiras verificaijtSes de transmissao acidental da molestia de Chagas ao homem por transfusao de sangue. Rev Paul Med 1952;40:36-40.
  • 3. Pinto-Dias JC, Brener Z. Chagas’ disease and blood transfusion. Mem Inst Oswaldo Cruz 1984;79:139-47.
  • 4. Moncayo A, Silveira AC. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 2009;104(Suppl. 1):17-30.
  • 5. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 2003;98:577-91.
  • 6. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007;102(Suppl. 1):75-85.
  • 7. Coura JR. The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions—a comprehensive review. Mem Inst Oswaldo Cruz 2015;110:277-82.
  • 8. Schmunis GA, Zicker F, Cruz JR, Cuchi P. Safety of blood supply for infectious diseases in Latin American countries, 1994-1997. Am J Trop Med Hyg 2001;65: 924-30.
  • 9. Schmunis GA, Cruz JR. Safety of the blood supply in Latin America. Clin Microbiol Rev 2005;18:12-29.
  • 10. Schmunis GA. Risk of Chagas disease through transfusions in the Americans. Medicina (B Aires) 1999;59(Suppl. 2):125-34.
  • 11. Schmunis GA. Trypanosoma cruzi, the etiologic agent of Chagas’ disease: status in the blood supply in endemic and nonendemic countries. Transfusion 1991;31:547-57.
  • 12. Angheben A, Boix L, Buonfrate D, Gobbi F, Bisoffi Z, Pupella S, et al. Chagas disease and transmission medicine: a perspective from non-endemic countries. Blood Transfusion 2015;13:540-50.
  • 13. Coura JR. Chagas disease: control, elimination and eradication. Is it possible? Mem Inst Oswaldo Cruz 2013;108:962-7.
  • 14. Medina JR. Blood safety in the XXI century. Transfusion transmitted infectious diseases. International and Mexican view. Gaceta Medica De Mexico 2014;150:78-83.
  • 15. Cantey PT, Stramer SL, Townsend RL, Kamel H, Ofafa K, Todd CW, et al. The United States Trypanosoma cruzi infection study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion 2012;52:1922-30.
  • 16. Garcia MN, Aguilar D, Gorchakov R, Rossmann SN, Montgomery SP, Rivera H, et al. Evidence of autochthonous Chagas disease in Southeastern Texas. Am J Trop Med Hyg 2015;92:325-30.
  • 17. Navin TR, Roberto RR, Juranek DD, Limpakarnjanarat K, Mortenson EW, Clover JR, et al. Human and sylvatic Trypanosoma cruzi infection in California. Am J Public Health 1985;75:366-9.
  • 18. Steele LS, MacPherson DW, Kim J, Keystone JS, Gushulak BD. The sero-prevalence of antibodies to Trypanosoma cruzi in Latin American refugees and immigrants to Canada. J Immigr Minor Health 2007;9:43-7.
  • 19. Ueno Y, Nakamura Y, Takahashi M, Inoue T, Endo S, Kinoshita M, et al. A highly suspected case of chronic Chagas’ heart disease diagnosed in Japan. Jpn Circ J 1995;59:219-23.
  • 20. Imai K, Maeda T, Sayama Y, Osa M, Mikita K, Kurane I, et al. Chronic Chagas disease with advanced cardiac complications in Japan: case report and literature review. Parasitol Int 2015;64:240-2.
  • 21. Imai K, Maeda T, Sayama Y, Mikita K, Fujikura Y, Misawa K, et al. Mother-to-child transmission of congenital Chagas disease, Japan. Emerg Infect Dis 2014;20:146-8.
  • 22. Pinto A, Pett S, Jackson Y. Identifying Chagas disease in Australia: an emerging challenge for general practitioners. Aust Fam Physician 2014;43:440-2.
  • 23. Jackson Y, Pinto A, Pett S. Chagas disease in Australia and New Zealand: risks and needs for public health interventions. Trop Med Int Health 2014;19:212-18.
  • 24. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 2010;115:14-21.
  • 25. Frank M, Hegenscheid B, Janitschke K, Weinke T. Prevalence and epidemiological significance of Trypanosoma cruzi infection among Latin American immigrants in Berlin, Germany. Infection 1997;25:355-8.
  • 26. El Ghouzzi MH, Boiret E, Wind F, Brochard C, Fittere S, Paris L, et al. Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening. Transfusion 2010;50:575-83.
  • 27. Gabrielli S, Girelli G, Vaia F, Santonicola M, Fakeri A, Cancrini G. Surveillance of Chagas disease among at-risk blood donors in Italy: preliminary results from Umberto I Polyclinic in Rome. Blood Transfusion 2013;11:558-62.
  • 28. Jackson Y, Getaz L, Wolff H, Holst M, Mauris A, Tardin A, et al. Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS NTD 2010;4:e592.
  • 29. Sandahl K, Botero-Kleiven S, Hellgren U. Chagas’ disease in Sweden—great need of guidelines for testing. Probably hundreds of seropositive cases, only a few known. Lakartidningen 2011;108:2368-71.
  • 30. Kitchen AD, Hewitt PE, Chiodini PL. The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem. Transfusion 2012;52:1931-9.
  • 31. Galel SA, Kirchhoff LV. Risk factors for Trypanosoma cruzi infection in California blood donors. Transfusion 1996;36:227-31.
  • 32. Leiby DA, Herron Jr. RM, Read EJ, Lenes BA, Stumpf RJ. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seropreva- lence and implications for transfusion transmission. Transfusion 2002;42:549-55.
  • 33. Kerndt PR, Waskin HA, Kirchhoff LV, Steurer F, Waterman SH, Nelson JM, et al. Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California. Transfusion 1991;31:814-18.
  • 34. Strasen J, Williams T, Ertl G, Zoller T, Stich A, Ritter O. Epidemiology of Chagas disease in Europe: many calculations, little knowledge. Clin Res Cardiol 2014;103: 1 - 10.
  • 35. Basile L, Jansa JM, Carlier Y, Salamanca DD, Angheben A, Bartoloni A, et al. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill 2011;16.
  • 36. Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other nonendemic countries. Acta Trop 2010;115:22-7.
  • 37. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009;49:E52-4.
  • 38. Grant IH, Gold JW, Wittner M, Tanowitz HB, Nathan C, Mayer K, et al. Transfusion- associated acute Chagas disease acquired in the United States. Ann Intern Med 1989;111:849-51.
  • 39. Nickerson P, Orr P, Schroeder ML, Sekla L, Johnston JB. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann Intern Med 1989;111:851-3.
  • 40. Cimo PL, Luper WE, Scouros MA. Transfusion-associated Chagas’ disease in Texas: report of a case. Tex Med 1993;89:48-50.
  • 41. Leiguarda R, Roncoroni A, Taratuto AL, Jost L, Berthier M, Nogues M, et al. Acute CNS infection by Trypanosoma cruzi (Chagas’ disease) in immunosuppressed patients. Neurology 1990;40:850-1.
  • 42. Leiby DA, Lenes BA, Tibbals MA, Tames-Olmedo MT. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999;341:1237-9.
  • 43. Young C, Losikoff P, Chawla A, Glasser L, Forman E. Transfusion-acquired Trypanosoma cruzi infection. Transfusion 2007;47:540-4.
  • 44. Kessler DA, Shi PA, Avecilla ST, Shaz BH. Results of lookback for Chagas disease since the inception of donor screening at New York blood center. Transfusion 2013; 53:1083-7.
  • 45. Blumental S, Lambermont M, Heijmans C, Rodenbach MP, El Kenz H, Sondag D, et al. First documented transmission of Trypanosoma cruzi infection through blood transfusion in a child with sickle-cell disease in Belgium. PLoS NTD 2015;9:e0003986.
  • 46. Flores-Chavez M, Fernandez B, Puente S, Torres P, Rodriguez M, Monedero C, et al. Transfusional Chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin Infect Dis 2008;46:e44-7.
  • 47. Benjamin RJ, Stramer SL, Leiby DA, Dodd RY, Fearon M, Castro E. Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission. Transfusion 2012;52:1913-21, quiz 2.
  • 48. Cancino-Faure B, Fisa R, Riera C, Bula I, Girona-Llobera E, Jimenez-Marco T. Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood donors. Transfusion 2015;55:1249-55.
  • 49. Nussenzweig V, Sonntag R, Biancalana A, De Freitas JL, Amato Neto V, Kloetzel J. Effect of triphenylmethane dyes on Trypanosoma cruzi in vitro; use of gentian violet in prevention of transmission of Chagas disease by blood transfusion. Hospital (Rio J) 1953;44:731-44.
  • 50. Nussenzweig V, Biancalana A, Amato Neto V, Sonntag R, De Freitas JP, Kloetzel J. Effect of gentian violet on Trypanosoma cruzi in vitro; importance in the sterilization of blood for transfusion. Rev Paul Med 1953;42:57-8.
  • 51. Diaz Gomez MI, Castro JA. Genotoxicidad en leucocitos por la quimioprofilaxis de sangre con violeta de genciana y su prevencitSn con antioxidantes. Acta Bioq Clin Latinoamer 2013;47:719-26.
  • 52. Moraes-Souza H, Bordin JO. Strategies for prevention of transfusion-associated Chagas’ disease. Transfus Med Rev 1996;10:161-70.
  • 53. Moraes-Souza H, Bordin JO, Bardossy L, Blajchman MA. Treatment of T. cruzi infected human platelet concentrates with aminomethyltrimethyl psoralen (AMT) and ultraviolet a (UV-A) light: preliminary results. Rev Soc Bras Med Trop 1996;29:47-9.
  • 54. Levin MJ. Molecular mimicry and Chagas’ heart disease: High anti-R-13 autoantibody levels are markers of severe Chagas heart complaint. Res Immunol 1991;142:157-9.
  • 55. Carvalho MR, Krieger MA, Almeida E, Oelemann W, Shikanai-Yassuda MA, Ferreira AW, et al. Chagas’ disease diagnosis: evaluation of several tests in blood bank screening. Transfusion 1993;33:830-4.
  • 56. Vergara U, Veloso C, Gonzalez A, Lorca M. Evaluation of an enzyme-linked immunosorbent assay for the diagnosis of Chagas’ disease using synthetic peptides. Am J Trop Med Hyg 1992;46:39-43.
  • 57. Gomes ML, Galvao LM, Macedo AM, Pena SD, Chiari E. Chagas’ disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods. Am J Trop Med Hyg 1999;60:205-10.
  • 58. Umezawa ES, Luquetti AO, Levitus G, Ponce C, Ponce E, Henriquez D, et al. Serodiagnosis of chronic and acute Chagas’ disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six latin American countries. J Clin Microbiol 2004;42:449-52.
  • 59. Pirard M, Iihoshi N, Boelaert M, Basanta P, Lopez F, Van der Stuyft P. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 2005;45:554-61.
  • 60. Escamilla-Guerrero G, Martinez-Gordillo MN, Riveron-Negrete L, Aguilar-Escobar DV, Bravo-Lindoro A, Cob-Sosa C, et al. Trypanosoma cruzi: seroprevalence detected in the blood bank of the Instituto Nacional de Pediatria, Mexico city, in the period 2004 through 2009. Transfusion 2012;52:595-600.
  • 61. Brasil PE, Castro R, Castro L. Commercial enzyme-linked immunosorbent assay versus polymerase chain reaction for the diagnosis of chronic Chagas disease: a systematic review and meta-analysis. Mem Inst Oswaldo Cruz 2016;111:1-19.
  • 62. Breniere SF, Poch O, Selaes H, Tibayrenc M, Lemesre JL, Antezana G, et al. Specific humoral depression in chronic patients infected by Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo 1984;26:254-8.
  • 63. Degrave W, Fragoso SP, Britto C, van Heuverswyn H, Kidane GZ, Cardoso MA, et al. Peculiar sequence organization of kinetoplast DNA minicircles from Trypanosoma cruzi. Mol Biochem Parasitol 1988;27:63-70.
  • 64. Avila HA, Pereira JB, Thiemann O, De Paiva E, DeGrave W, Morel CM, et al. Detection of Trypanosoma cruzi in blood specimens of chronic Chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis. J Clin Microbiol 1993;31:2421-6.
  • 65. Wincker P, Bosseno MF, Britto C, Yaksic N, Cardoso MA, Morel CM, et al. High correlation between Chagas’ disease serology and PCR-based detection of Trypanosoma cruzi kinetoplast DNA in Bolivian children living in an endemic area. FEMS Microbiol Lett 1994;124:419-23.
  • 66. Wincker P, Telleria J, Bosseno MF, Cardoso MA, Marques P, Yaksic N, et al. PCR-based diagnosis for Chagas’ disease in Bolivian children living in an active transmission area: comparison with conventional serological and parasitological diagnosis. Parasitology 1997;114(Pt 4):367-73.
  • 67. Breniere SF, Bosseno MF, Noireau F, Yacsik N, Liegeard P, Aznar C, et al. Integrate study of a Bolivian population infected by Trypanosoma cruzi, the agent of Chagas disease. Mem Inst Oswaldo Cruz 2002;97:289-95.
  • 68. Schijman AG, Bisio M, Orellana L, Sued M, Duffy T, Mejia Jaramillo AM, et al. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS NTD 2011;5:e931.
  • 69. Anez N, Carrasco H, Parada H, Crisante G, Rojas A, Gonzalez N, et al. Acute Chagas’ disease in Western Venezuela: a clinical, seroparasitologic, and epidemiologic study. Am J Trop Med Hyg 1999;60:215-22.
  • 70. Reesink HW. European strategies against the parasite transfusion risk. Transfus Clin Biol 2005;12:1-4.
  • 71. Appleman MD, Shulman IA, Saxena S, Kirchhoff LV. Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi. Transfusion 1993; 33:61-4.
  • 72. O’Brien SF, Ram SS, Vamvakas EC, Goldman M. The Canadian blood donor health assessment questionnaire: lessons from history, application of cognitive science principles, and recommendations for change. Transfus Med Rev 2007;21: 205 22.
  • 73. O’Brien SF, Scalia V, Goldman M, Fan W, Yi QL, Dines IR, et al. Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian blood services. Transfusion 2013;53:1706-13.
  • 74. O’Brien SF, Chiavetta JA, Fan W, Xi G, Yi QL, Goldman M, et al. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion 2008;48:755-61.
  • 75. Galel SA, Lifson JD, Engleman EG. Prevention of AIDS transmission through screening of the blood supply. Annu Rev Immunol 1995;13:201-27.
  • 76. Aznar C, Liegeard P, Mariette C, Lafon S, Levin MJ, Hontebeyrie M. A simple Trypanosoma cruzi enzyme-linked immunoassay for control of human infection in nonendemic areas. FEMS Immunol Med Microbiol 1997;18:31-7.
  • 77. Verani JR, Seitz A, Gilman RH, LaFuente C, Galdos-Cardenas G, Kawai V, et al. Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. Am J Trop Med Hyg 2009;80:410-15.
  • 78. Nagarkatti R, de Araujo FF, Gupta C, Debrabant A. Aptamer based, non-PCR, non-serological detection of Chagas disease biomarkers in Trypanosoma cruzi infected mice. PLoS NTD 2014;8:e2650.
  • 79. Pinazo MJ, Thomas MC, Bustamante J, Almeida IC, Lopez MC, Gascon J. Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives. Mem Inst Oswaldo Cruz 2015;110:422-32.
  • 80. WHO. Blood donor counselling: implementation guidelines, Geneva: World Health Organization; 2014.
  • 81. Vazquez MC, Riarte A, Pattin M, Lauricella M. Chagas-disease can be transmitted through kidney-transplantation. Transpl Proc 1993;25:3259-60.
  • 82. CDC. From the Centers for Disease Control and Prevention. Chagas disease after organ transplantation—United States, 2001. JAMA 2002;287:1795-6.
  • 83. (CDC) CfDCaP. Chagas disease after organ transplantation—Los Angeles, California, 2006. MMWR 2006;55:798-800.
  • 84. Defaria JBL, Alves G. Transmission of Chagas-disease through cadaveric renal- transplantation. Transplantation 1993;56:1583-4.
  • 85. Ferraz AS, Figueiredo JFC. Transmission of Chagas’ disease through transplanted kidney: occurrence of the acute form of the disease in two recipients from the same donor. Rev Inst Med Trop Sao Paulo 1993;35:461-3.
  • 86. Riarte A, Luna C, Sabatiello R, Sinagra A, Schiavelli R, De Rissio A, et al. Chagas’ disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis 1999;29:561-7.
  • 87. D’Albuquerque LA, Gonzalez AM, Filho HL, Copstein JL, Larrea FI, Mansero JM, et al. Liver transplantation from deceased donors serologically positive for Chagas disease. Am J Transplant 2007;7:680-4.
  • 88. Kun H, Moore A, Mascola L, Steurer F, Lawrence G, Kubak B, et al. Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis 2009;48:1534-40.
  • 89. Lattes R, Altclas J, Arselan S, Barcan L, Diez M, Gadano A, et al. Chagas’ disease and solid organ transplantation. Transplant Proc 2010;42:3354-9.
  • 90. Huprikar S, Bosserman E, Patel G, Moore A, Pinney S, Anyanwu A, et al. Donor- derived Trypanosoma cruzi infection in solid organ recipients in the United States, 2001-2011. Am J Transplant 2013;13:2418-25.
  • 91. Souza FF, Castro ESO, Marin Neto JA, Sankarankutty AK, Teixeira AC, Martinelli AL, et al. Acute Chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report. Transplant Proc 2008;40:875- 8.
  • 92. Chin-Hong PV, Schwartz BS, Bern C, Montgomery SP, Kontak S, Kubak B, et al. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in transplant working group. Am J Transplant 2011;11:672-80.
  • 93. Pinazo MJ, Miranda B, Rodriguez-Villar C, Altclas J, Brunet Serra M, Garcia-Otero EC, et al. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev (Orlando) 2011;25:91-101.
  • 94. Bertolino ND, Villafanha DF, Cardinalli-Neto A, Cordeiro JA, Arcanjo MJ, Theodoropoulos TA, et al. Prognostic impact of Chagas’ disease in patients awaiting heart transplantation. J Heart Lung Transplant 2010;29:449-53.
  • 95. Kransdorf EP, Czer LS, Luthringer DJ, Patel JK, Montgomery SP, Velleca A, et al. Heart transplantation for Chagas cardiomyopathy in the United States. Am J Transplant 2013;13:3262-8.
  • 96. Sadala ML, Stolf NA, Bicudo MA. Heart transplantation: the experience of patients with Chagas disease. Rev Esc Enferm USP 2009;43:588-95.
  • 97. Diez M, Favaloro L, Bertolotti A, Burgos JM, Vigliano C, Lastra MP, et al. Usefulness of PCR strategies for early diagnosis of Chagas’ disease reactivation and treatment follow-up in heart transplantation. Am J Transplant 2007;7:1633-40.
  • 98. Benvenuti LA, Roggerio A, Sambiase NV, Fiorelli A, Higuchi Mde L. Polymerase chain reaction in endomyocardial biopsies for monitoring reactivation of Chagas’ disease in heart transplantation: a case report and review of the literature. Cardiovasc Pathol 2005;14:265-8.
  • 99. Freitas HF, Chizzola PR, Paes AT, Lima AC, Mansur AJ. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas’ heart disease. Int J Cardiol 2005;102:239-47.
  • 100. Fiorelli AI, Santos RH, Oliveira Jr. JL, Lourenco-Filho DD, Dias RR, Oliveira AS, et al. Heart transplantation in 107 cases of Chagas’ disease. Transplant Proc 2011;43: 220-4.
  • 101. Bestetti RB, Theodoropoulos TA. A systematic review of studies on heart transplantation for patients with end-stage Chagas’ heart disease. J Card Fail 2009;15:249-55.
  • 102. Coudert J, Despeignes J, Battesti MR, Michel-Brun J. A case of Chagas’ disease caused by accidental laboratory contamination by T. cruzi. Bull Soc Pathol Exot Filiales 1964; 57:208-13.
  • 103. Pizzi T, Niedmann G, Jarpa A. Report of 3 cases of acute Chagas’ disease produced by accidental laboratory infections. Bol Chil Parasitol 1963;18:32-6.
  • 104. Brener Z. Laboratory-acquired Chagas’ disease: an endemic disease among parasitologists. In: Morel CME, editor. Genes and antigens of parasites: a laboratory manual. Rio de Janeiro, Brazil: Fundaijao Oswaldo Cruz; 1984. p. 39.
  • 105. Hofflin JM, Sadler RH, Araujo FG, Page WE, Remington JS. Laboratory-acquired Chagas disease. Trans R Soc Trop Med Hyg 1987;81:437-40.
  • 106. Herwaldt BL. Laboratory-acquired parasitic infections from accidental exposures. Clin Microbiol Rev 2001;14:659-88, table of contents.
  • 107. Dias JCP, Amato Neto V. Prevencao referente as modalidades alternativas de transmis- sao do Trypanosoma cruzi no Brasil. Rev Soc Brasil Med Trop 2011;44:68-72.
  • 108. Brener Z, Alquezar AS, Luquetti AS. Normas de seguranca para infeccoes acidentais com o Trypanosoma cruzi, agente causador da doenca de Chagas. Rev Patol Trop 1997;26:129-30.
  • 109. Andrade JP, Marin Neto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al. I Latin American guidelines for the diagnosis and treatment of Chagas’ heart disease: Executive summary. Arq Bras Cardiol 2011;96:434-42.
  • 110. Kinoshita-Yanaga AT, Toledo MJ, Araujo SM, Vier BP, Gomes ML. Accidental infection by Trypanosoma cruzi follow-up by the polymerase chain reaction: Case report. Rev Inst Med Trop Sao Paulo 2009;51:295-8.
  • 111. Brumpt E. Precis de parasitologie. Paris: Masson et Cie; 1927.
  • 112. Dias E. Xenodiagnostico e algumas verificacoes epidemiologicas na molestia de Chagas. In: Regional RdSdP, editor. Buenos Aires, vol. 1; 1935, p. 89-119.
  • 113. Dias E. Estudos sobre o Schizotrypanum cruzi. Rio de Janeiro: Universidade de Rio de Janeiro; 1933.
  • 114. Nattan-Larrier L. Infections a Trypanosomes et voies de penetrations des virus. Bull Soc Path Exot 1921;26:2579.
  • 115. Torrico RA. Conocimientos actuales sobre la enfermedad de Chagas en Bolivia. Bol Of Sanit Panam 1950;29:827-41.
  • 116. Diaz-Ungria C. Transmision del Trypanosoma cruzi en los vertebrados. Rev Ibe'r Parasitol Today 1965;25:1-44.
  • 117. Mayer HF. Infeccion experimental con Trypanosoma cruzi por via digestive. Anales Inst Med Regional 1961;5:43-8.
  • 118. Baretto MP, Ribeiro RD, Belda Neto FM. Estudos sobre reservatorios e vectores silvestres do Trypanosoma cruzi. Lxviii: Infeccao de mamiferos pela via oral. Rev Bras Biol 1978;38:45569.
  • 119. Schenone H, Gonzalez H, Schenone H, Rojas A. Infeccion experimental de ratas con Trypanosoma cruzi por via oral. Bol Chile Parasit 1982;37:29.
  • 120. Calvo MML, Nogueda B, Aguilar RA. Oral route: a probable way of transmission of Trypanosoma cruzi. Rev Lat-amer Microbiol 1992;34:39-42.
  • 121. Marsden PD. Trypanosoma cruzi infections in CFI mice. II. Infections induced by different routes. Ann Trop Med Parasitol 1967;61:62-7.
  • 122. Jansen AM, Moriearty PL, Castro BG, Deane MP. Trypanosoma cruzi in the opossum Didelphis marsupialis: an indirect fluorescent antibody test for the diagnosis and follow-up of natural and experimental infections. Trans R Soc Trop Med Hyg 1985;79: 474-7.
  • 123. Ribeiro DR, Rissato e Garcia TA, Bonomo WC. Contribuicao para o estudo dos mecanismos de transmissao do agente etiologico da doenija de Chagas. Rev Saude Publ Sao Paulo 1987;21:51-4.
  • 124. da Silva NN, Clausell DT, Nolibos H, de Mello AL, Ossanai J, Rapone T, et al. Epidemic outbreak of Chagas disease probably due to oral contamination. Rev Inst Med Trop Sao Paulo 1968;10:265-76.
  • 125. Shikanai-Yasuda MA, Marcondes CB, Guedes LA, Siqueira GS, Barone AA, Dias JC, et al. Possible oral transmission of acute Chagas’ disease in Brazil. Rev Inst Med Trop Sao Paulo 1991;33:351-7.
  • 126. Neves Pinto AY, Valente SA, Valente VC, Ferreira AG, Coura JR. Fase aguda da doenca de Chagas na Amazonia Brasileira. Estudo de 233 casos de para, amapae maranhao observados entre 1988 e 2005. Rev Soc Bras Med Trop 2008;41:602-14.
  • 127. Steindel M, Kramer Pacheco L, Scholl D, Soares M, de Moraes MH, Eger I, et al. Characterization of Trypanosoma cruzi isolated from humans, vectors, and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, Brazil. Diagn Microbiol Infect Dis 2008;60:25-32.
  • 128. Valente S.A.S., Valente V.C., Pin A.Y. Epidemiologia e transmissao oral da doenca de Chagas na Amazonia Brasiliera. In: Organizacion Panamericana de la Salud/ Organizacion Mundial de la Salud W, editor. Informe de la consulta tecnica em epidemiologia, prevencion y manejo de la transmission de la enfermedad de Chagas como enfermedad transmitida por alimentos (ETA); 2006. p. 21—6.
  • 129. Nobrega AA, Garcia MH, Tatto E, Obara MT, Costa E, Sobel J, et al. Oral transmission of Chagas disease by consumption of acai palm fruit, Brazil. Emerg Infect Dis 2009;15:653—5.
  • 130. Coura JR, Junqueira AC. Surveillance, health promotion and control of Chagas disease in the Amazon region-medical attention in the Brazilian Amazon region: a proposal. Mem Inst Oswaldo Cruz 2015;110:825—30.
  • 131. de Noya BA, Gonzalez ON. An ecological overview on the factors that drives to Trypanosoma cruzi oral transmission. Acta Trop 2015;151:94—102.
  • 132. Coura JR. Special issue on Chagas disease. Mem Inst Oswaldo Cruz 2015;110:275—6.
  • 133. Alarcon de Noya B, Diaz-Bello Z, Colmenares C, Ruiz-Guevara R, Mauriello L, Zavala-Jaspe R, et al. Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela. J Infect Dis 2010;201:1308—15.
  • 134. Blanchet D, Breniere SF, Schijman AG, Bisio M, Simon S, Veron V, et al. First report of a family outbreak of Chagas disease in French Guiana and posttreatment follow-up. Infect Genet Evol 2014;28:245—50.
  • 135. Santalla-Vargas J, Oporto P, Espinoza E, Rios T, Brutus L. Primer brote reportado de la enfermedad de Chagas en la Amazonia Boliviana: reporte de 14 casos agudos por transmision oral de Trypanosoma cruzi en Guayaramenn, Beni-bolivia. BIOFARBO 2011;19:52—8.
  • 136. Coura JR, Junqueira AC, Fernandes O, Valente SA, Miles MA. Emerging Chagas disease in Amazonian Brazil. Trends Parasitol 2002;18:171—6.
  • 137. PAHO/WHO, Organizacion Panamericana de la Salud/Organizacion Mundial de la Salud W, editor. Informe de la consulta tecnica em epidemiologia, prevencion y manejo de la transmission de la enfermedad de Chagas como enfermedad transmitida por alimentos (ETA) 2006.
  • 138. Ribeiro M, Nitz N, Santana C, Moraes A, Hagstrom L, Andrade R, et al. Sexual transmission of Trypanosoma cruzi in murine model. Exp Parasitol 2016;162:1—6.
  • 139. Carvalho LO, Abreu-Silva AL, Hardoim Dde J, Tedesco RC, Mendes VG, da Costa SC, et al. Trypanosoma cruzi and myoid cells from seminiferous tubules: interaction and relation with fibrous components of extracellular matrix in experimental Chagas’ disease. Int J Exp Pathol 2009;90:52—7.
  • 140. Carvalho TL, Ribeiro RD, Lopes RA. The male reproductive organs in experimental Chagas’ disease. I. Morphometric study of the vas deferens in the acute phase of the disease. Exp Pathol 1991;41:203 —14.
  • 141. Herrera L, Urdaneta-Morales S. Experimental transmission of Trypanosoma cruzi through the genitalia of albino mice. Mem Inst Oswaldo Cruz 2001;96:713—17.
  • 142. Martin DL, Lowe KR, McNeill T, Thiele EA, Roellig DM, Zajdowicz J, et al. Potential sexual transmission of Trypanosoma cruzi in mice. Acta Trop 2015;149:15—18.
  • 143. Teixeira AR, Roters F, Mott KE. Acute Chagas disease. Gaz Med Bahia 1970;70:176e—86e.
  • 144. Jorg ME, Oliva R. Presencia de tripomastigotes en sangue menstrual de mujeres con Trypanosoma cruzi. Rev Arg Parasitol 1980;1.
  • 145. Concetti H, Retegui M, Perez G, Perez H. Chagas’ disease of the cervix uteri in a patient with acquired immunodeficiency syndrome. Hum Pathol 2000;31:120—2.
 
Source
< Prev   CONTENTS   Source   Next >